{"id":913842,"date":"2025-11-25T17:04:41","date_gmt":"2025-11-25T22:04:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/"},"modified":"2025-11-25T17:04:41","modified_gmt":"2025-11-25T22:04:41","slug":"anaptys-announces-participation-in-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/","title":{"rendered":"Anaptys Announces Participation in December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Nov.  25, 2025  (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:<\/p>\n<p>\n        <strong>Piper Sandler 37th Annual Healthcare Conference, New York, NY<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and 1&#215;1 investor meetings<\/li>\n<li>Date and Time \u2013 Tuesday, Dec. 2, 2025 at 1:30pm ET<\/li>\n<\/ul>\n<p>\n        <strong>Evercore 8th Annual Healthcare Conference, Coral Gables, FL<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and 1&#215;1 investor meetings<\/li>\n<li>Date and Time \u2013 Wednesday, Dec. 3, 2025 at 7:55am ET<\/li>\n<\/ul>\n<p>Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7fUrtpyL-aWhYOrpvG8H8Q9VJlrbE3ebtQEdLKcLioFLDr3YFmWePLDJSYNCTIXLZz9HMoSbvTCd_Kw8efXFMNk6f7y22wdu00kiPuV5XFA6sNj-hEJFxTzIgdnueeZLLsxwsdw0Bam2VB9Mb0lQ8RvBFjV_LuRDQ6aQkH9Gehc=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.anaptysbio.com\/presentations-and-events<\/a>. Replays of the webcasts will be available for at least 30 days following the events.<\/p>\n<p>\n        <strong>About Anaptys<\/strong>\n      <\/p>\n<p>Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. The company\u2019s pipeline includes rosnilimab, a pathogenic T cell depleter, which has completed a Phase 2b trial for rheumatoid arthritis; ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease with plans to expand development into an additional indication; and ANB101, a BDCA2 modulator, in a Phase 1a trial. Anaptys has also discovered and out-licensed in financial collaborations multiple therapeutic antibodies, including a PD-1 antagonist (<em>Jemperli<\/em>\u00a0(dostarlimab-gxly)) to GSK and an IL-36R antagonist (imsidolimab) to Vanda Pharmaceuticals.\u00a0To learn more, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jVwRFsAyoMnWBFFLRQOHwNj9g6fuUKKZ1HNj-zaji43wBm45NS53gR9kF2KojTJdvyksfgcdnZXu46JKkUHpWBNI91TJ79TCSFfMJDQrwvjeMwbPzpowUzlwCJs7UwdYke5Vaw52XHEGsE5991a5-RSUGZHWlzUnrIG4rAux59mjWZlXYxUcP7gZGDrANdgOIv40-kT_fumM_wXrlg8SRDo5nheVRNx84IPEAKt4Fq8LFFug5HBKMcKtsNyF-xAGmf2zN1lfbCtj2we9rMhpFw==\" rel=\"nofollow\" target=\"_blank\"><u>www.AnaptysBio.com<\/u><\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F6le0IsURuNvqHdDHr2QGwRMhkf2KUAg9CkYvB3zSkEBro_-FfrXVBxLBHgdR4hzWy3sw_bssbYV3kIrUtG8jj9ZRu0_cOoQ0UekJudHRE_srXNFSH8kVmJsI5WbxTDCTvFJhqZ6ux4jRmovuqaGirvwzE5EXkJWYa7RJ6wwh1-JSgB854Zd3ju9aLghVy2kIB0V7W6ojJFaKo0-NJ1-9ZIGbhgS9xvC43u2_JdkBGh96_791O0g-UUSv5PuKEu5\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>Anaptys recently announced the intent to separate its biopharma operations from its substantial royalty assets by year-end 2026, enabling investors to align their investment philosophies and portfolio allocation with the strategic opportunities and financial objectives of each company. Learn more\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jmavyNKyJboKGQ90-fQtGRWFlvYuMyV3UL6aSBaqYqPNuTlRsYOH4b7yQAMLcvfdCgoOpNjssdPVzVjiSGxVWhjLgEloDSDAP4Ul9reVOFaFUg2SHGjbvsipbiwM2pdt2Tqd4BuITCIXOY-TlZZqAZq8y8SRaBestr3R3OyCy4w6hycoosZohjqU6Tvb0uScX5_2wrG9S44Q2bY2V51pA8Iew9ofybmO4Kopwfmnrd7tsPn4SBSHYkpifIyZBL58bfueNmBUVNEQm4OHTOm2A4sWodz8GSheo74KLQIP2iKPcDiQ1kVK2X3Jl2pByxpqN80EYLK1DUUC_lfwZtL0kg5C_RNwgIKzFCxnmu9j-7VOutkK_A7UNCopsxj4X5RtjMafsulM3_fj9uGacIbQ5mUCXXaciN0oCN3IlqIDBP3IEF_35iDmsUUdTsVu0WSG_F4-SqdEIRtlZkBlMTJ7L80jP4ZEOh75PJx7JeglEiVbsIDj-EiunZL_Y1IKJgXnQ0AaDr1zgFu1RJDyAWAscy9oGQYhmS17zM5n1wWOnTThuCcdaa68zM9MeTRDrLylmRV8vphNBnqFxKzPdqWY1IG90nvdLMCVRAPnTHhm2tWFS3PP4vfshqKgRfhjSnt9VyJCOc_Krwvmmqxabbm1K9mOHeHGfrDJ_rtq44R0dO5aYlVmTjJ6PNotksQMN5YqKziiIW-uu94_DLLUHmpRvN7s-WhgdrRuMeZQ_u_GFfnaN46pjtw4iGJTDVLu2sgarCce7BWoy22J7aaGma9sxBccUc6Pa-ZmluewJT2ZrHzxTyPZFmG1IwHeyFZc7RfOCSCpfOhOjHRBzIS0Io-_8GIP8Xps-ZgTOnM8aY3geQ2Bw1wgt4plm415Q9pVuWrV7CEY1m8WOzoTT2m2FJpFIoXdf9ypF67Dqk_d7ZIgABqB9JHZ3qBB1CGvkfEKwZU5FERKvJYL6VEpDgYubNdL99c0laaf_8vfPrOUnLceXhUzhw-iCqr56ReBialsRqMUGT23MyGpsmYQQ1Rra2WMYOl1YX9bCV11dXcKQqfNcy2qH3AgPvTOzTK1HraGk-5H1N9LmD1Yh18mXUUnEbDwxQ==\" rel=\"nofollow\" target=\"_blank\"><u>here<\/u><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Nick Montemarano<br \/>Executive Director, Investor Relations<br \/>858.732.0178<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=boW_XYDUq_e3vTynKQQFg6HH51KwdSA4V6VosVtdR9o3J9QNF8U303VKr4e3TFqje-RDaQyNoSMDCN8Xe-z_nPtduTrfxE9VuGISWK-OfDWrelUWPSayhNEzOlw3KAfy\" rel=\"nofollow\" target=\"_blank\">investors@anaptysbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjFkZmYxN2YtNWZlMS00MDJkLWFlNWEtMWJmZjRlMWYwOWQxLTEwMzE2OTgtMjAyNS0xMS0yNS1lbg==\/tiny\/AnaptysBio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference, New York, NY Format \u2013 Fireside chat and 1&#215;1 investor meetings Date and Time \u2013 Tuesday, Dec. 2, 2025 at 1:30pm ET Evercore 8th Annual Healthcare Conference, Coral Gables, FL Format \u2013 Fireside chat and 1&#215;1 investor meetings Date and Time \u2013 Wednesday, Dec. 3, 2025 at 7:55am ET Live webcasts of the fireside chats will be available on the investor section of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Anaptys Announces Participation in December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913842","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anaptys Announces Participation in December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anaptys Announces Participation in December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference, New York, NY Format \u2013 Fireside chat and 1&#215;1 investor meetings Date and Time \u2013 Tuesday, Dec. 2, 2025 at 1:30pm ET Evercore 8th Annual Healthcare Conference, Coral Gables, FL Format \u2013 Fireside chat and 1&#215;1 investor meetings Date and Time \u2013 Wednesday, Dec. 3, 2025 at 7:55am ET Live webcasts of the fireside chats will be available on the investor section of &hellip; Continue reading &quot;Anaptys Announces Participation in December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T22:04:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Anaptys Announces Participation in December Investor Conferences\",\"datePublished\":\"2025-11-25T22:04:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/\",\"name\":\"Anaptys Announces Participation in December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=\",\"datePublished\":\"2025-11-25T22:04:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anaptys-announces-participation-in-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anaptys Announces Participation in December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anaptys Announces Participation in December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Anaptys Announces Participation in December Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference, New York, NY Format \u2013 Fireside chat and 1&#215;1 investor meetings Date and Time \u2013 Tuesday, Dec. 2, 2025 at 1:30pm ET Evercore 8th Annual Healthcare Conference, Coral Gables, FL Format \u2013 Fireside chat and 1&#215;1 investor meetings Date and Time \u2013 Wednesday, Dec. 3, 2025 at 7:55am ET Live webcasts of the fireside chats will be available on the investor section of &hellip; Continue reading \"Anaptys Announces Participation in December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-25T22:04:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Anaptys Announces Participation in December Investor Conferences","datePublished":"2025-11-25T22:04:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/"},"wordCount":302,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/","name":"Anaptys Announces Participation in December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=","datePublished":"2025-11-25T22:04:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjIzNSM3MjkyNTk3IzIwMjAxMjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anaptys-announces-participation-in-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Anaptys Announces Participation in December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913842"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}